ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) insider Christopher Mutz sold 2,000 shares of the stock in a transaction that occurred on Tuesday, May 21st. The stock was sold at an average price of $61.61, for a total value of $123,220.00. Following the completion of the transaction, the insider now directly owns 83,277 shares […]
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) insider Christopher Mutz sold 2,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 21st. The shares were sold at an average price of $61.61, for a total value of $123,220.00. Following the transaction, the insider now owns 83,277 shares of the company’s […]
StockNews.com downgraded shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) from a buy rating to a hold rating in a report published on Saturday. Separately, HC Wainwright dropped their price target on TRACON Pharmaceuticals from $120.00 to $60.00 and set a buy rating on the stock in a research report on Wednesday, April 3rd. Check […]
CASI Pharmaceuticals (NASDAQ:CASI – Free Report) had its price target reduced by HC Wainwright from $12.00 to $6.00 in a research report report published on Wednesday, Benzinga reports. They currently have a buy rating on the biotechnology company’s stock. HC Wainwright also issued estimates for CASI Pharmaceuticals’ Q2 2024 earnings at ($0.63) EPS, Q3 2024 […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) was the recipient of a large increase in short interest in April. As of April 30th, there was short interest totalling 12,030,000 shares, an increase of 7.8% from the April 15th total of 11,160,000 shares. Based on an average trading volume of 1,810,000 shares, the short-interest ratio […]